Xcout IntelSign inSubscribe

Zafrens

BiologyUnited States

Zafrens Inc. is a biotechnology and pharmaceutical company headquartered in San Diego, California, pioneering advanced life science tools and platforms.

Subscribe to see Zafrens’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Zafrens at a glance

Zafrens is a biology company headquartered in United States. Its most recent funding round, Series A, raised $31M in February 2025. Xcout tracks 3 named people at Zafrens, including Swamy Vijayan (FOUNDER).

Industry
Biology
Headquarters
United States

Zafrens leadership

  • Swamy VijayanFOUNDER
  • Vikas GoelSUSTAINABILITY DIRECTOR
  • Yi ZhangDESIGN DIRECTOR

Zafrens funding rounds

Every round on record:

DateRoundAmountInvestors
Series A$31M3 named
SEC Form D filing$6.2M—

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Investors

Zafrens competitors

A few of Zafrens's closest competitors — see the full list of competitors and alternatives →

Get Zafrens's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Zafrens — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Zafrens in Xcout Intel

  • 3 named people with titles, LinkedIn and board committees
  • 2 funding rounds with the investors in each, and who they co-invest with
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →